ID   HMT-3909S16
SY   HMT3909S16; HMT-3909 subline S16
DR   cancercelllines; CVCL_UW68
DR   Wikidata; Q94213584
RX   PubMed=11801722;
RX   PubMed=16807805;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Purified myoepithelial cell line.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UW65 ! HMT-3909S13
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
RX   PubMed=11801722; DOI=10.1242/jcs.115.1.39;
RA   Gudjonsson T., Ronnov-Jessen L., Villadsen R., Rank F., Bissell M.J.,
RA   Petersen O.W.;
RT   "Normal and tumor-derived myoepithelial cells differ in their ability
RT   to interact with luminal breast epithelial cells for polarity and
RT   basement membrane deposition.";
RL   J. Cell Sci. 115:39-50(2002).
RX   PubMed=16807805; DOI=10.1007/s10911-005-9586-4;
RA   Gudjonsson T., Adriance M.C., Sternlicht M.D., Petersen O.W.,
RA   Bissell M.J.;
RT   "Myoepithelial cells: their origin and function in breast
RT   morphogenesis and neoplasia.";
RL   J. Mammary Gland Biol. Neoplasia 10:261-272(2005).